News & Articles

Watch this on-demand webinar to discover the benefits of sample preparation strategies for clinical sample matrices

As the WHO set guidelines for measuring COVID-19 viral loads during clinical diagnosis, one research group challenged the accuracy of this metric (and provided a better alternative)

Data shows that iota-carrageenan might be an effective virus blocker irrespective of present and possible future SARS-CoV-2 mutations

The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron, and its stealth version

The lab-based Atellica and ADVIA Centaur SARS-CoV-2 Antigen Assays (CoV2Ag) are well designed to detect Omicron variant

Learn how antibody researchers teamed up with a biologics manufacturer to develop novel diagnostic tests and treatments for viral infections

A study by experts at King's College London has found that symptoms of early COVID-19 are similar to vaccine side-effects

Study shows people with severe mental illnesses experience significantly poorer outcomes resulting from COVID-19 which are only partly explained by pre-existing physical health conditions

Find out how unbiased lab product reviews are changing the world of science - and why not get involved yourself?

Leading clinicians discuss the latest developments in point of care testing for cardiac disease, myocardial infarction, and blood gas analysis

Even though viral measurements are fairly standardized, a different metric was used to quantify SARS-CoV-2. Read how one research team investigated this disparity

From single-cell analysis to GC, genomics, and lessons from COVID-19, watch leading experts online to discover the latest tools and techniques to advance your work

Both vaccines are highly effective and either one is strongly recommended

Models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments

bioMérieux conducts in-depth analyses of its molecular tests on emerging variants of concern

Seegene will support countries in need of diagnostics to help slow Omicron's spread

the In silico analysis of lineage B.1.1.529 (Omicron) is applicable to the VIASURE range of products

Discover the latest resources and innovative tools driving immuno-oncology research forward

Discover insights on topics from lab automation and gene therapy to monoclonal antibodies and clinical diagnostics

Company testing three existing COVID-19 vaccine booster candidates against the Omicron variant

Data are now available from all enrolled participants